Intervention Review

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

  1. G Mustafa Soomro1,*,
  2. Douglas G Altman2,
  3. Sundararajan Rajagopal3,
  4. Mark Oakley Browne4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 11 NOV 2007

DOI: 10.1002/14651858.CD001765.pub3

How to Cite

Soomro GM, Altman DG, Rajagopal S, Oakley Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001765. DOI: 10.1002/14651858.CD001765.pub3.

Author Information

  1. 1

    St. George's Hospital Medical School, Department of Psychiatry, London, UK

  2. 2

    Wolfson College Annexe, Centre for Statistics in Medicine, Oxford, UK

  3. 3

    South London and Maudsley NHS Trust, Adamson Centre for Mental Health, London, UK

  4. 4

    School of Rural Health , Department of Rural and Indigenous Health , PO Box 973 Moe , Victoria, Australia

*G Mustafa Soomro, Department of Psychiatry, St. George's Hospital Medical School, University of London, Cranmer Terrace, London, SW17 0RE, UK. gms357@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

    G Mustafa Soomro, Douglas G Altman, Sundararajan Rajagopal and Mark Oakley Browne

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001765.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Serotonin re-uptake Inhibitors (SSRIs) versus placebo for obsessive compulsive disorders (OCD)

    M Soomro G., M Oakley-Browne and C Doughty

    Article first published online: 17 OCT 2007 | DOI: 10.1002/14651858.CD001765.pub2

  2. Version 1

    Serotonin re-uptake Inhibitors (SSRIs) versus placebo for obsessive compulsive disorders (OCD)

    G M Soomro, M Oakley-Browne and C Doughty

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD001765